Health
Novartis MS Treatment Shows Promising Results
A new treatment from Novartis significantly reduced the relapse rates of multiple sclerosis patients in pivotal trials, cutting them by a third compared to standard treatments. The breakthrough could offer hope for millions suffering from the disease.
Coverage timeline — 2 articles
STAT News
“I felt Christina Applegate’s disappointment as if it were my own — because not long ago, it was,” writes Lindsay Karp.
2026-10-23 16:39 UTC
STAT News
An MS treatment from Novartis cut by a third the rates of relapses compared to a standard treatment.
2026-10-23 16:47 UTC